Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction (NMJ). Autoantibodies target key molecules at the NMJ, such as the nicotinic acetylcholine receptor (AChR), muscle-specific kinase (MuSK), and low-density lipoprotein receptor-related protein 4 (Lrp4), that lead by a range...

Descripción completa

Detalles Bibliográficos
Autores principales: Koneczny, Inga, Herbst, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678492/
https://www.ncbi.nlm.nih.gov/pubmed/31269763
http://dx.doi.org/10.3390/cells8070671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678492/
https://www.ncbi.nlm.nih.gov/pubmed/31269763
http://dx.doi.org/10.3390/cells8070671

Ejemplares similares